BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31282337)

  • 1. [Research Advances in Ocular Myasthenia Gravis].
    Wu YJ; Yan L; Hu YX; Rao J; Xu XX; Cheng Y; Wu N; Wu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):402-407. PubMed ID: 31282337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular myasthenia gravis: an update on diagnosis and treatment.
    Fortin E; Cestari DM; Weinberg DH
    Curr Opin Ophthalmol; 2018 Nov; 29(6):477-484. PubMed ID: 30281029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Ocular Myasthenia Gravis.
    O'Hare M; Doughty C
    Semin Neurol; 2019 Dec; 39(6):749-760. PubMed ID: 31847046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular myasthenia gravis.
    Vaphiades MS; Bhatti MT; Lesser RL
    Curr Opin Ophthalmol; 2012 Nov; 23(6):537-42. PubMed ID: 23047171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Ocular Myasthenia Gravis.
    Smith SV; Lee AG
    Neurol Clin; 2017 Feb; 35(1):115-123. PubMed ID: 27886889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Myasthenia.
    Al-Haidar M; Benatar M; Kaminski HJ
    Neurol Clin; 2018 May; 36(2):241-251. PubMed ID: 29655447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research Advances in Follicular Regulatory T Cells in Ocular Myasthenia Gravis].
    Wu N; Hu Y; Xu X; Yan L; Cheng Y; Rao J; Wu Y; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):383-387. PubMed ID: 32616136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
    Ma R; Cheng Y; Gan L; Zhou X; Qian J
    BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
    Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
    Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular aspects of myasthenia gravis.
    Barton JJ; Fouladvand M
    Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
    Valko Y; Wirth MA; Fierz FC; Schesny MK; Rosengren S; Schmückle-Meier T; Bockisch CJ; Straumann D; Schreiner B; Weber KP
    Neurology; 2024 May; 102(10):e209395. PubMed ID: 38669629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Ocular Myasthenia Gravis.
    Cornblath WT
    Asia Pac J Ophthalmol (Phila); 2018; 7(4):257-259. PubMed ID: 30044061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.
    Sommer N; Melms A; Weller M; Dichgans J
    Doc Ophthalmol; 1993; 84(4):309-33. PubMed ID: 8156854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles.
    Europa TA; Nel M; Heckmann JM
    Neuromuscul Disord; 2019 May; 29(5):381-387. PubMed ID: 31029532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Ocular Myasthenia Gravis Associated with In Vitro Fertilization Procedures.
    Yoo YJ; Han SB; Yang HK; Hwang JM
    Optom Vis Sci; 2018 May; 95(5):475-478. PubMed ID: 29683988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular myasthenia gravis].
    Sanadze AG; Sidnev DV; Tumurov DA; Afanasieva OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(9):116-120. PubMed ID: 37796078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.